Clinical trial
Ibandronate Versus Placebo in the Prevention of Bone Loss After Renal…
NCT00423384 · Smerud Medical Research International AS, Other · Unknown status
Key facts
| NCT number | NCT00423384 |
|---|---|
| Title | Ibandronate Versus Placebo in the Prevention of Bone Loss After Renal Transplantation. |
| Official title | Ibandronate Versus Placebo as add-on to Active Vitamin D and Calcium in the Prevention of Bone Loss After Renal Transplantation. |
| Lead sponsor | Smerud Medical Research International AS, Other |
| Collaborators | Oslo University Hospital |
| Status | Unknown status |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Renal Transplant |
| Intervention type | Drug |
| Interventions | Placebo, Ibandronate |
| Enrollment | 130 |
| Start date | Jan 1, 2007 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2010 |
| First posted | Jan 18, 2007 |
| Last update posted | Mar 24, 2010 |
| Countries | Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: